Newsletter Tool

Featured Story

Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says

By Kevin Dunleavy

The FDA says it will move quickly to add a label warning about heart inflammation risks with the COVID-19 vaccines from Pfizer and Moderna. The CDC reports 309 hospitalizations linked to the rare risk, mostly among males aged 16 to 24, with no deaths.

FDA greenlights its first saliva-based COVID-19 antibody test

By Conor Hale

The FDA authorized its first antibody test that doesn’t use blood samples to check for evidence of a COVID-19 infection and instead relies on simple, painless mouth swabs. Developed by Diabetomics, the diagnostic is now allowed for used at the point of care for adults and children and delivers a result within 15 minutes.

House bill seeks to raise reimbursement for rural hospitals in bid to close payment disparity

By Robert King

A new House bill aims to raise the Medicare reimbursement for rural hospitals in an effort to close a pay disparity with urban facilities.

COVID-19 tracker: WHO predicts yearly boosters for most vulnerable: report

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The World Health Organization expects those most vulnerable to the coronavirus and troublesome variants will likely need yearly booster shots, while everyone else may need them every other year, Reuters reports. The FDA approved the first antibody test that doesn't require a blood sample. And more headlines.

COVID-19 Tracker

Featured Story

Pfizer, Moderna COVID-19 vaccines will get label warning over rare heart risk, FDA says

Top Stories

FDA greenlights its first saliva-based COVID-19 antibody test

House bill seeks to raise reimbursement for rural hospitals in bid to close payment disparity

COVID-19 tracker: WHO predicts yearly boosters for most vulnerable: report